Female—cervical screening indicator, yes/no/not stated/inadequately described code N
Identifying and definitional attributes | |
Metadata item type:![]() | Data Element |
---|---|
Short name:![]() | Cervical screening indicator |
Synonymous names:![]() | HPV test indicator |
METEOR identifier:![]() | 719551 |
Registration status:![]() |
|
Definition:![]() | An indicator of whether a female person has had a cervical screening, as represented by a code. |
Data Element Concept: | Female—cervical screening indicator |
Value domain attributes | |||||||
Representational attributes | |||||||
Representation class:![]() | Code | ||||||
---|---|---|---|---|---|---|---|
Data type:![]() | Number | ||||||
Format:![]() | N | ||||||
Maximum character length:![]() | 1 | ||||||
Permissible values:![]() |
| ||||||
Supplementary values:![]() |
| ||||||
Collection and usage attributes | |||||||
Guide for use:![]() | CODE 9 Not stated/inadequately described This code is not for use in primary data collections. | ||||||
Data element attributes | |||||||
Collection and usage attributes | |||||||
Comments:![]() | From 1 December 2017, the screening test for cervical cancer, the Pap test, changed to a test for the human papillomavirus (HPV) with partial HPV genotyping and reflex liquid-based cytology (LBC) triage. The procedure for collecting samples for HPV testing is the same as for having a Pap smear. A health-care professional will take a small sample of cells from the woman’s cervix. The sample will be sent to a pathology laboratory for examination. While the current Pap test can detect abnormal cell changes, the new cervical screening test will detect the HPV infection that can cause the abnormal cell changes, prior to the development of cancer. The recommended screening age for the HPV test is 25 to 74 years. (Under the previous screening test the age range was 18 to 69 and the data submitted was for the age range 20 to 69). The HPV test will be offered every 5 years (instead of every 2 as it was with the Pap test) (DoH 2017). A vaginal sample can also be taken by a woman, under supervision of her health-care professional (AIHW 2017). | ||||||
Source and reference attributes | |||||||
Submitting organisation:![]() | Australian Institute of Health and Welfare | ||||||
Reference documents:![]() | AIHW (Australian Institute of Health and Welfare) 2017. National Cervical Screening Program data dictionary: Version 1.0. Cancer series no. 103. Cat. no. CAN 102, Canberra. Viewed 18 July 2019, http://www.aihw.gov.au/publication-detail/?id=60129559625 DoH (Australian Government Department of Health) 2017. National Cervical Screening Program. DoH, Canberra. Viewed 24 July 2019, http://www.cancerscreening.gov.au/internet/screening/ | ||||||
Relational attributes | |||||||
Related metadata references:![]() | Has been superseded by Female—cervical screening indicator, yes/no/not stated/inadequately described code N
Supersedes Female—cervical screening indicator, yes/no/not stated/inadequately described code N
| ||||||
Implementation in Data Set Specifications:![]() All attributes + |
| ||||||
Implementation in Indicators:![]() |
|
Downloading
The download may take a while, please wait.
Do not refresh the screen until the download is complete.